• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结节病中的间质性肺疾病]

[Interstitial lung diseases in sarcoidosis].

作者信息

Bouvry Diane, Naccache Jean-Marc, Valeyre Dominique

机构信息

Service de pneumologie, hôpital Avicenne, GHU Nord, Assistance publique-hôpitaux de Paris et UFR SMBH Bobigny, Uuniversité Paris 13, 93009 Bobigny.

出版信息

Rev Prat. 2007 Dec 31;57(20):2258-65.

PMID:18320746
Abstract

Sarcoidosis is a multisystem disorder of unknown aetiology characterized by immune granuloma in involved tissue with predilection for lung and lymphoid system. The sarcoidosis aetiology remains unknown. It could result of genetic predisposition and exposure to specific enviromental factors. The chest X-ray is abnormal in 90% of cases with adenopathies and/or massive pulmonary infiltration with or without fibrosis. The different aspects are classified in 4 stages. The diagnosis is done when clinical and radiological usual signs are present with histological granuloma without caseum and in the absence of any other granulomatous disease. Most of the time, sarcoidosis spontaneously heals in 2 to 3 years. 10 to 30% of cases are chronic and often more severe. The disease could lastly generate a pulmonary fibrosis with a potential respiratory insufficiency, cor pulmonale, or aspergillus infection. Cardiac, neurologic, throat, kidney or ophthalmologic lesions or hypercalcemia may also be of bad prognosis. Sarcoidosis is lethal in 0.5 to 5% of cases. Mild disease does not need to be treated. Systemic corticosteroid for 12 months at least is the treatment for more severe diseases. Antimalarials drugs and immunomodulatory agents may be used if corticosteroids cannot be used or failed. TNFalpha recently proposed is currently evaluated.

摘要

结节病是一种病因不明的多系统疾病,其特征为受累组织中出现免疫性肉芽肿,好发于肺和淋巴系统。结节病的病因仍不清楚。它可能是遗传易感性和接触特定环境因素所致。90%的病例胸部X线检查异常,表现为淋巴结肿大和/或有或无纤维化的大量肺部浸润。不同表现分为4期。当出现临床和放射学常见征象,伴有无干酪样坏死的组织学肉芽肿,且无任何其他肉芽肿性疾病时,可作出诊断。大多数情况下,结节病在2至3年内可自发痊愈。10%至30%的病例呈慢性,且往往病情更严重。该疾病最终可能导致肺纤维化,伴有潜在的呼吸功能不全、肺心病或曲霉菌感染。心脏、神经、咽喉、肾脏或眼科病变或高钙血症也可能预后不良。结节病在0.5%至5%的病例中是致命的。轻症无需治疗。对于病情较重的疾病,至少需使用全身性皮质类固醇治疗12个月。如果不能使用皮质类固醇或治疗失败,可使用抗疟药和免疫调节剂。最近提出的肿瘤坏死因子α目前正在进行评估。

相似文献

1
[Interstitial lung diseases in sarcoidosis].[结节病中的间质性肺疾病]
Rev Prat. 2007 Dec 31;57(20):2258-65.
2
Pulmonary sarcoidosis.肺结节病
Semin Respir Crit Care Med. 2007 Feb;28(1):53-74. doi: 10.1055/s-2007-970333.
3
Clinical presentation of sarcoidosis and diagnostic work-up.结节病的临床表现和诊断方法。
Semin Respir Crit Care Med. 2014 Jun;35(3):336-51. doi: 10.1055/s-0034-1381229. Epub 2014 Jul 9.
4
Pulmonary sarcoidosis: management.肺结节病:管理
J Postgrad Med. 2002 Apr-Jun;48(2):135-41.
5
[Severe pulmonary sarcoidosis].[重症肺结节病]
Ann Med Interne (Paris). 2001 Mar;152(2):96-102.
6
Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes.结节病性肺纤维化。临床特征和结局。
Ann Am Thorac Soc. 2013 Aug;10(4):362-70. doi: 10.1513/AnnalsATS.201303-069FR.
7
[Granulomatous diseases and pathogenic microorganism].[肉芽肿性疾病与致病微生物]
Kekkaku. 2008 Feb;83(2):115-30.
8
Pulmonary sarcoidosis.肺结节病。
Lancet Respir Med. 2018 May;6(5):389-402. doi: 10.1016/S2213-2600(18)30064-X. Epub 2018 Apr 3.
9
Paediatric sarcoidosis.儿科类肉瘤病。
Paediatr Respir Rev. 2019 Feb;29:53-59. doi: 10.1016/j.prrv.2018.05.003. Epub 2018 May 19.
10
[Thoracic sarcoidosis].[胸段结节病]
Presse Med. 2010 Jan;39(1):93-106. doi: 10.1016/j.lpm.2009.10.010. Epub 2009 Dec 2.